European VC Directory

Venture capital firm investing in high-growth technology companies.

Venture capital firm investing in high-growth technology companies.

Venture capital firm investing in high-growth technology companies.

Venture capital firm investing in high-growth technology companies.

Venture capital firm investing in high-growth technology companies.

Venture capital firm investing in high-growth technology companies.

Venture capital firm investing in high-growth technology companies.

Venture capital firm investing in high-growth technology companies.

Venture capital firm investing in high-growth technology companies.

Venture capital firm investing in high-growth technology companies.

Invests in global life sciences innovation across therapeutics, medical devices, and diagnostics, leveraging Kleiner Perkins' life sciences expertise to support company building worldwide.

Panache Ventures

Montreal, CA

Panache Ventures is Canada’s leading pre-seed & seed fund, dedicated to backing visionary founders from day one. They aim to be the first institutional investor on the cap table, providing initial investments up to $1.5M from their $100M Fund II. Panache focuses on supporting technology founders across all sectors nationwide, with hands-on support from operators-turned-investors. They emphasize a no-ego approach, focusing on practical assistance rather than board seats. The firm's strategy revolves around identifying and investing in founders with conviction and courage, providing them with the resources and support needed to scale their companies. Panache offers more than just capital, delivering operator-led support, leveraging a network of over 100 founders who have grown with their assistance. They do not emphasize board seats but a hands-on approach to mentorship and support. Panache emphasizes a national presence, implying a focus on the Canadian market and a commitment to supporting founders across the country. They highlight their experience as former operators, suggesting a practical, hands-on approach to helping their portfolio companies overcome challenges and achieve growth. The absence of ego suggests a collaborative and founder-centric approach, prioritizing the needs of the entrepreneurs they back.

Panakès Partners

IT

Panakès Partners is a venture capital firm focused on investing in Life Sciences companies. Their mission is to improve people's lives globally by backing promising teams and providing financial and business support to build game-changing technology companies. They target ambitious early-stage start-ups and SMEs with innovative products, primarily in Europe and Israel, but with a global outlook. Panakès goes beyond simply providing capital. They bring strong entrepreneurial and financial expertise to their portfolio companies and leverage a wide network of clinicians and industry experts. They emphasize building relationships with selected industrial partners to assist founders in accelerating development, suggesting a hands-on approach and a commitment to helping companies scale and navigate the complexities of the life sciences industry. Panakès invests in people, recognizing that a strong and dedicated team is a crucial factor for investment success. They aim to actively collaborate with entrepreneurs to build successful businesses as an engaged and well-connected investor. The fund supports the growth of companies and individuals that will reshape the medical world, addressing real medical needs, saving lives, and improving quality of life, aiming for a positive impact for both investors and society.

Venture capital firm investing in high-growth technology companies.

Venture capital firm investing in high-growth technology companies.

Venture capital firm investing in high-growth technology companies.

Pareto

Invests in early growth companies with high potential to become globalized, aiming to support and accelerate their success.

Park Rangers Capital is a pre-seed and seed firm that focuses on backing founders with a built-in distribution edge. Their investment philosophy is rooted in the belief that software has become a commodity and that the loneliness epidemic in the U.S. is a significant problem. They believe the strongest companies of the next decade will address both by building communities, where users belong and are deeply connected to the brand. They seek founders who are building movements early on, with companies whose members are obsessive, loyal, and deeply connected to the brand, referring to these founders as 'elephants, not unicorns.' The firm's focus extends beyond mere product creation, emphasizing the importance of community building. They aim to support founders in turning customers into members and companies into movements, recognizing that distribution, community, and authenticity are key moats in today's market. They provide support in three core areas: content & storytelling, community access, and distribution strategy. Park Rangers Capital emphasizes the use of content to distribute ideas, build trust, and connect with founders. They are a solo GP shop supported by a Chief of Staff, venture partner, fractional writer, and a network of operators. Erica Wenger, the solo GP, has experience as a serial entrepreneur and early operator.

Venture capital firm investing in high-growth technology companies.

Venture capital firm investing in high-growth technology companies.

Venture capital firm investing in high-growth technology companies.

Venture capital firm investing in high-growth technology companies.

Based on the provided website content, it is challenging to create a comprehensive investment thesis and strategy description for Parkway Venture Capital. The crawled pages primarily consist of news articles from Maddyness, a French tech news publication, and do not provide detailed information about Parkway Venture Capital's investment approach. The content touches on investment in startups, particularly within the French tech ecosystem, and features on various startups and funds, however, it does not describe Parkway Venture Capital's specific preferences.

Venture capital firm investing in high-growth technology companies.